135 related articles for article (PubMed ID: 30105825)
1. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
[TBL] [Abstract][Full Text] [Related]
2. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
[TBL] [Abstract][Full Text] [Related]
3. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for non-malignant shoulder syndrome: Is there a risk for radiation-induced carcinogenesis?
Mazonakis M; Lyraraki E; Tzedakis A; Damilakis J
Phys Med; 2017 Nov; 43():73-78. PubMed ID: 29195566
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for stage I seminoma of the testis: Organ equivalent dose to partially in-field structures and second cancer risk estimates on the basis of a mechanistic, bell-shaped, and plateau model.
Mazonakis M; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2015 Nov; 42(11):6309-16. PubMed ID: 26520723
[TBL] [Abstract][Full Text] [Related]
6. Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma.
Mazonakis M; Lyraraki E; Damilakis J
Med Phys; 2017 Jul; 44(7):3866-3874. PubMed ID: 28493609
[TBL] [Abstract][Full Text] [Related]
7. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
[TBL] [Abstract][Full Text] [Related]
8. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy.
Akmansu M; Dirican B; Bora H; Gurel O
Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty.
Mazonakis M; Berris T; Lyraraki E; Damilakis J
Med Phys; 2013 Oct; 40(10):101702. PubMed ID: 24089892
[TBL] [Abstract][Full Text] [Related]
10. Probability of carcinogenesis due to involved field and involved site radiation therapy techniques for supra- and infradiaphragmatic Hodgkin's disease.
Kourinou KM; Mazonakis M; Lyraraki E; Papadaki HΑ; Damilakis J
Phys Med; 2019 Jan; 57():100-106. PubMed ID: 30738513
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
12. Risk of contralateral breast and ipsilateral lung cancer induction from forward-planned IMRT for breast carcinoma.
Mazonakis M; Stratakis J; Lyraraki E; Damilakis J
Phys Med; 2019 Apr; 60():44-49. PubMed ID: 31000085
[TBL] [Abstract][Full Text] [Related]
13. Monte carlo study of organ doses and related risk for cancer in Tanzania from scattered photons in cervical radiation treatment involving Co-60 source.
Suleiman SA; Qi Y; Chen Z; Xu XG
Phys Med; 2019 Jun; 62():13-19. PubMed ID: 31153393
[TBL] [Abstract][Full Text] [Related]
14. Secondary bladder and rectal cancer risk estimates following standard fractionated and moderately hypofractionated VMAT for prostate carcinoma.
Mazonakis M; Kachris S; Damilakis J
Med Phys; 2020 Jul; 47(7):2805-2813. PubMed ID: 32266979
[TBL] [Abstract][Full Text] [Related]
15. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
Suleiman SA; Qi Y; Pi Y; George Xu X
Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
[TBL] [Abstract][Full Text] [Related]
16. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract][Full Text] [Related]
17. Development of clinical application program for radiotherapy induced cancer risk calculation using Monte Carlo engine in volumetric-modulated arc therapy.
Kang DJ; Shin YJ; Jeong S; Jung JY; Lee H; Lee B
Radiat Oncol; 2021 Jun; 16(1):108. PubMed ID: 34118968
[TBL] [Abstract][Full Text] [Related]
18. Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer.
Donovan EM; James H; Bonora M; Yarnold JR; Evans PM
Med Phys; 2012 Oct; 39(10):5814-24. PubMed ID: 23039620
[TBL] [Abstract][Full Text] [Related]
19. SECOND CANCER RISK FROM RADIATION THERAPY FOR COMMON SOLID TUMORS DIAGNOSED IN REPRODUCTIVE-AGED FEMALES.
Mazonakis M; Kachris S; Damilakis J
Radiat Prot Dosimetry; 2018 Dec; 182(2):208-214. PubMed ID: 29608744
[TBL] [Abstract][Full Text] [Related]
20. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy.
Yoon M; Shin DH; Kim J; Kim JW; Kim DW; Park SY; Lee SB; Kim JY; Park HJ; Park BK; Shin SH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):637-46. PubMed ID: 20932690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]